Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2021 作为临床和伦理目标,临床医生应如何以同情心执行重要强制干预,而非仅仅将伤害最小化? Robert L. Trestman(理学博士、医学博士) and Kishore Nagaraja(医学博士) AMA J Ethics. 2021; E292-297. doi: 10.1001/amajethics.2021.292. Case and Commentary Apr 2021 ¿Cómo deberían los médicos clínicos ejecutar intervenciones con medidas de fuerza críticas para salvar una vida con compasión, no solo para minimizar el daño, como un objetivo clínico y ético? Robert L. Trestman, PhD, MD and Kishore Nagaraja, MD AMA J Ethics. 2021; E292-297. doi: 10.1001/amajethics.2021.292. Medicine and Society Apr 2016 Reproductive Rights and Access to Reproductive Services for Women with Disabilities Anita Silvers, PhD, Leslie Francis, JD, PhD, and Brittany Badesch Women with disabilities may be prevented access to reproductive medicine due to discrimination and mistaken assumptions about disabled people. AMA J Ethics. 2016; 18(4):430-437. doi: 10.1001/journalofethics.2016.18.4.msoc1-1604. Case and Commentary Apr 2021 How Should Clinicians Execute Critical Force Interventions With Compassion, Not Just Harm Minimization, as a Clinical and Ethical Goal? Robert L. Trestman, PhD, MD and Kishore Nagaraja, MD Establishing criteria for compassion maximization would help us do better than harm minimization. AMA J Ethics. 2021; 23(4):E292-297. doi: 10.1001/amajethics.2021.292. Case and Commentary Apr 2021 Who Should Implement Force When It’s Needed and How Should It Be Done Compassionately? Matthew Lin, MD Covert medication administration might be as forceful as physical or chemical restraint for patients lacking insight. AMA J Ethics. 2021; 23(4):E311-317. doi: 10.1001/amajethics.2021.311. Case and Commentary Apr 2021 在需要时应由谁实施强制措施,以及如何以富有同理心的方式实施? Matthew Lin(医学硕士) AMA J Ethics. 2021; E311-317. doi: 10.1001/amajethics.2021.311. Case and Commentary Apr 2021 ¿Quién debería aplicar la fuerza en caso de ser necesario y cómo hacerlo con compasión? Matthew Lin, MD AMA J Ethics. 2021; E311-317. doi: 10.1001/amajethics.2021.311. State of the Art and Science May 2021 What We Know About Long-acting Injectable Antipsychotics Can Help Innovate HIV Care Olivia S. Kates, MD Long-acting injectables powerfully augment HIV care, but broad acceptance and uptake could be compromised by what we know about experiences with antipsychotics. AMA J Ethics. 2021; 23(5):E405-409. doi: 10.1001/amajethics.2021.405. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021; 23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021; 23(9):E697-701. doi: 10.1001/amajethics.2021.697. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Apr 2021 作为临床和伦理目标,临床医生应如何以同情心执行重要强制干预,而非仅仅将伤害最小化? Robert L. Trestman(理学博士、医学博士) and Kishore Nagaraja(医学博士) AMA J Ethics. 2021; E292-297. doi: 10.1001/amajethics.2021.292.
Case and Commentary Apr 2021 ¿Cómo deberían los médicos clínicos ejecutar intervenciones con medidas de fuerza críticas para salvar una vida con compasión, no solo para minimizar el daño, como un objetivo clínico y ético? Robert L. Trestman, PhD, MD and Kishore Nagaraja, MD AMA J Ethics. 2021; E292-297. doi: 10.1001/amajethics.2021.292.
Medicine and Society Apr 2016 Reproductive Rights and Access to Reproductive Services for Women with Disabilities Anita Silvers, PhD, Leslie Francis, JD, PhD, and Brittany Badesch Women with disabilities may be prevented access to reproductive medicine due to discrimination and mistaken assumptions about disabled people. AMA J Ethics. 2016; 18(4):430-437. doi: 10.1001/journalofethics.2016.18.4.msoc1-1604.
Case and Commentary Apr 2021 How Should Clinicians Execute Critical Force Interventions With Compassion, Not Just Harm Minimization, as a Clinical and Ethical Goal? Robert L. Trestman, PhD, MD and Kishore Nagaraja, MD Establishing criteria for compassion maximization would help us do better than harm minimization. AMA J Ethics. 2021; 23(4):E292-297. doi: 10.1001/amajethics.2021.292.
Case and Commentary Apr 2021 Who Should Implement Force When It’s Needed and How Should It Be Done Compassionately? Matthew Lin, MD Covert medication administration might be as forceful as physical or chemical restraint for patients lacking insight. AMA J Ethics. 2021; 23(4):E311-317. doi: 10.1001/amajethics.2021.311.
Case and Commentary Apr 2021 在需要时应由谁实施强制措施,以及如何以富有同理心的方式实施? Matthew Lin(医学硕士) AMA J Ethics. 2021; E311-317. doi: 10.1001/amajethics.2021.311.
Case and Commentary Apr 2021 ¿Quién debería aplicar la fuerza en caso de ser necesario y cómo hacerlo con compasión? Matthew Lin, MD AMA J Ethics. 2021; E311-317. doi: 10.1001/amajethics.2021.311.
State of the Art and Science May 2021 What We Know About Long-acting Injectable Antipsychotics Can Help Innovate HIV Care Olivia S. Kates, MD Long-acting injectables powerfully augment HIV care, but broad acceptance and uptake could be compromised by what we know about experiences with antipsychotics. AMA J Ethics. 2021; 23(5):E405-409. doi: 10.1001/amajethics.2021.405.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021; 23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021; 23(9):E697-701. doi: 10.1001/amajethics.2021.697.